Bone Marrow Transplantation

Transfusion Treatment Evaluated For BMT Patients

Published in Blood Weekly, June 21st, 2001

University of Florida researchers have found there is no danger in waiting longer than usual to administer a certain type of transfusion to cancer patients who have undergone bone marrow transplantation - a discovery that may decrease demands on blood reserves and reduce transfusion-related side effects.

They presented their findings at the annual meeting of the American Society of Clinical Oncology during May 2001.

Each year, an estimated 40,000 people worldwide undergo bone marrow transplant (BMT). The high doses of chemotherapy and radiation these patients receive wreak havoc on platelets, rendering the patients prone to potentially lethal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-06-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry